nodes	percent_of_prediction	percent_of_DWPC	metapath
Tamoxifen—CYP19A1—Betamethasone—ankylosing spondylitis	0.0743	0.0878	CbGbCtD
Tamoxifen—ABCC2—Sulfasalazine—ankylosing spondylitis	0.0561	0.0664	CbGbCtD
Tamoxifen—CYP1B1—Dexamethasone—ankylosing spondylitis	0.0533	0.063	CbGbCtD
Tamoxifen—ABCB11—Dexamethasone—ankylosing spondylitis	0.0533	0.063	CbGbCtD
Tamoxifen—ABCG2—Sulfasalazine—ankylosing spondylitis	0.0508	0.06	CbGbCtD
Tamoxifen—CYP2A6—Prednisolone—ankylosing spondylitis	0.0464	0.0549	CbGbCtD
Tamoxifen—CYP19A1—Dexamethasone—ankylosing spondylitis	0.0432	0.0511	CbGbCtD
Tamoxifen—CYP3A5—Sulfasalazine—ankylosing spondylitis	0.0281	0.0332	CbGbCtD
Tamoxifen—ABCC2—Dexamethasone—ankylosing spondylitis	0.028	0.0331	CbGbCtD
Tamoxifen—CYP2A6—Dexamethasone—ankylosing spondylitis	0.0274	0.0324	CbGbCtD
Tamoxifen—ABCG2—Dexamethasone—ankylosing spondylitis	0.0253	0.03	CbGbCtD
Tamoxifen—ABCB1—Methylprednisolone—ankylosing spondylitis	0.0242	0.0286	CbGbCtD
Tamoxifen—CYP1A1—Dexamethasone—ankylosing spondylitis	0.0234	0.0276	CbGbCtD
Tamoxifen—ABCC2—Methotrexate—ankylosing spondylitis	0.0225	0.0266	CbGbCtD
Tamoxifen—ABCG2—Methotrexate—ankylosing spondylitis	0.0204	0.0241	CbGbCtD
Tamoxifen—CYP3A7—Dexamethasone—ankylosing spondylitis	0.0187	0.0221	CbGbCtD
Tamoxifen—CYP3A7-CYP3A51P—Dexamethasone—ankylosing spondylitis	0.0187	0.0221	CbGbCtD
Tamoxifen—CYP2C19—Prednisone—ankylosing spondylitis	0.0181	0.0214	CbGbCtD
Tamoxifen—CYP2E1—Dexamethasone—ankylosing spondylitis	0.0181	0.0214	CbGbCtD
Tamoxifen—CYP2B6—Dexamethasone—ankylosing spondylitis	0.0178	0.0211	CbGbCtD
Tamoxifen—ABCB1—Betamethasone—ankylosing spondylitis	0.0157	0.0186	CbGbCtD
Tamoxifen—ABCB1—Prednisolone—ankylosing spondylitis	0.0155	0.0183	CbGbCtD
Tamoxifen—ABCB1—Prednisone—ankylosing spondylitis	0.0146	0.0173	CbGbCtD
Tamoxifen—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0145	0.0171	CbGbCtD
Tamoxifen—CYP3A5—Dexamethasone—ankylosing spondylitis	0.014	0.0166	CbGbCtD
Tamoxifen—CYP2C8—Dexamethasone—ankylosing spondylitis	0.0135	0.016	CbGbCtD
Tamoxifen—CYP2C19—Dexamethasone—ankylosing spondylitis	0.0113	0.0134	CbGbCtD
Tamoxifen—CYP3A4—Triamcinolone—ankylosing spondylitis	0.011	0.013	CbGbCtD
Tamoxifen—CYP2C9—Dexamethasone—ankylosing spondylitis	0.00941	0.0111	CbGbCtD
Tamoxifen—CYP3A4—Betamethasone—ankylosing spondylitis	0.00941	0.0111	CbGbCtD
Tamoxifen—CYP3A4—Prednisolone—ankylosing spondylitis	0.00928	0.011	CbGbCtD
Tamoxifen—ABCB1—Dexamethasone—ankylosing spondylitis	0.00913	0.0108	CbGbCtD
Tamoxifen—CYP3A4—Prednisone—ankylosing spondylitis	0.00877	0.0104	CbGbCtD
Tamoxifen—CYP2D6—Dexamethasone—ankylosing spondylitis	0.00861	0.0102	CbGbCtD
Tamoxifen—ABCB1—Methotrexate—ankylosing spondylitis	0.00734	0.00868	CbGbCtD
Tamoxifen—CYP3A4—Dexamethasone—ankylosing spondylitis	0.00547	0.00647	CbGbCtD
Tamoxifen—Myocardial infarction—Betamethasone—ankylosing spondylitis	0.0003	0.00195	CcSEcCtD
Tamoxifen—Myocardial infarction—Dexamethasone—ankylosing spondylitis	0.0003	0.00195	CcSEcCtD
Tamoxifen—Arrhythmia—Prednisolone—ankylosing spondylitis	0.000294	0.00191	CcSEcCtD
Tamoxifen—Pancreatitis—Prednisone—ankylosing spondylitis	0.000293	0.0019	CcSEcCtD
Tamoxifen—Visual impairment—Methylprednisolone—ankylosing spondylitis	0.000291	0.00189	CcSEcCtD
Tamoxifen—Osteoarthritis—Methotrexate—ankylosing spondylitis	0.000289	0.00188	CcSEcCtD
Tamoxifen—Erythema—Prednisolone—ankylosing spondylitis	0.000287	0.00186	CcSEcCtD
Tamoxifen—Neutropenia—Prednisone—ankylosing spondylitis	0.00028	0.00181	CcSEcCtD
Tamoxifen—Haemoglobin—Dexamethasone—ankylosing spondylitis	0.000276	0.00179	CcSEcCtD
Tamoxifen—Haemoglobin—Betamethasone—ankylosing spondylitis	0.000276	0.00179	CcSEcCtD
Tamoxifen—Erectile dysfunction—Prednisone—ankylosing spondylitis	0.000276	0.00179	CcSEcCtD
Tamoxifen—Haemorrhage—Betamethasone—ankylosing spondylitis	0.000275	0.00178	CcSEcCtD
Tamoxifen—Haemorrhage—Dexamethasone—ankylosing spondylitis	0.000275	0.00178	CcSEcCtD
Tamoxifen—Mood swings—Methotrexate—ankylosing spondylitis	0.000274	0.00178	CcSEcCtD
Tamoxifen—Weight increased—Prednisone—ankylosing spondylitis	0.000272	0.00177	CcSEcCtD
Tamoxifen—Arrhythmia—Triamcinolone—ankylosing spondylitis	0.000271	0.00176	CcSEcCtD
Tamoxifen—Weight decreased—Prednisone—ankylosing spondylitis	0.000271	0.00176	CcSEcCtD
Tamoxifen—Arrhythmia—Methylprednisolone—ankylosing spondylitis	0.00027	0.00175	CcSEcCtD
Tamoxifen—Liver function test abnormal—Methotrexate—ankylosing spondylitis	0.000267	0.00173	CcSEcCtD
Tamoxifen—Depression—Prednisone—ankylosing spondylitis	0.000266	0.00173	CcSEcCtD
Tamoxifen—Visual impairment—Betamethasone—ankylosing spondylitis	0.000265	0.00172	CcSEcCtD
Tamoxifen—Visual impairment—Dexamethasone—ankylosing spondylitis	0.000265	0.00172	CcSEcCtD
Tamoxifen—Erythema—Triamcinolone—ankylosing spondylitis	0.000264	0.00171	CcSEcCtD
Tamoxifen—Erythema—Methylprednisolone—ankylosing spondylitis	0.000263	0.00171	CcSEcCtD
Tamoxifen—Acute coronary syndrome—Prednisone—ankylosing spondylitis	0.000263	0.00171	CcSEcCtD
Tamoxifen—Angioedema—Prednisolone—ankylosing spondylitis	0.000262	0.0017	CcSEcCtD
Tamoxifen—Myocardial infarction—Prednisone—ankylosing spondylitis	0.000262	0.0017	CcSEcCtD
Tamoxifen—Dysgeusia—Triamcinolone—ankylosing spondylitis	0.000258	0.00168	CcSEcCtD
Tamoxifen—Back pain—Triamcinolone—ankylosing spondylitis	0.000255	0.00166	CcSEcCtD
Tamoxifen—Hypertension—Prednisolone—ankylosing spondylitis	0.000248	0.00161	CcSEcCtD
Tamoxifen—Arrhythmia—Dexamethasone—ankylosing spondylitis	0.000246	0.00159	CcSEcCtD
Tamoxifen—Arrhythmia—Betamethasone—ankylosing spondylitis	0.000246	0.00159	CcSEcCtD
Tamoxifen—Pancreatitis—Methotrexate—ankylosing spondylitis	0.000245	0.00159	CcSEcCtD
Tamoxifen—Alopecia—Dexamethasone—ankylosing spondylitis	0.000243	0.00158	CcSEcCtD
Tamoxifen—Alopecia—Betamethasone—ankylosing spondylitis	0.000243	0.00158	CcSEcCtD
Tamoxifen—Discomfort—Prednisolone—ankylosing spondylitis	0.000241	0.00157	CcSEcCtD
Tamoxifen—Angioedema—Triamcinolone—ankylosing spondylitis	0.000241	0.00156	CcSEcCtD
Tamoxifen—Haemoglobin—Prednisone—ankylosing spondylitis	0.000241	0.00156	CcSEcCtD
Tamoxifen—Angioedema—Methylprednisolone—ankylosing spondylitis	0.000241	0.00156	CcSEcCtD
Tamoxifen—Abdominal discomfort—Methotrexate—ankylosing spondylitis	0.00024	0.00155	CcSEcCtD
Tamoxifen—Haemorrhage—Prednisone—ankylosing spondylitis	0.000239	0.00155	CcSEcCtD
Tamoxifen—Erythema—Betamethasone—ankylosing spondylitis	0.000239	0.00155	CcSEcCtD
Tamoxifen—Erythema—Dexamethasone—ankylosing spondylitis	0.000239	0.00155	CcSEcCtD
Tamoxifen—Pancytopenia—Methotrexate—ankylosing spondylitis	0.000237	0.00154	CcSEcCtD
Tamoxifen—Oedema—Prednisolone—ankylosing spondylitis	0.000234	0.00152	CcSEcCtD
Tamoxifen—Neutropenia—Methotrexate—ankylosing spondylitis	0.000234	0.00152	CcSEcCtD
Tamoxifen—Erectile dysfunction—Methotrexate—ankylosing spondylitis	0.00023	0.00149	CcSEcCtD
Tamoxifen—Cough—Triamcinolone—ankylosing spondylitis	0.00023	0.00149	CcSEcCtD
Tamoxifen—Hypertension—Triamcinolone—ankylosing spondylitis	0.000228	0.00148	CcSEcCtD
Tamoxifen—Hypertension—Methylprednisolone—ankylosing spondylitis	0.000227	0.00147	CcSEcCtD
Tamoxifen—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.000226	0.00147	CcSEcCtD
Tamoxifen—Myalgia—Triamcinolone—ankylosing spondylitis	0.000225	0.00146	CcSEcCtD
Tamoxifen—Pneumonia—Methotrexate—ankylosing spondylitis	0.000224	0.00145	CcSEcCtD
Tamoxifen—Myalgia—Methylprednisolone—ankylosing spondylitis	0.000224	0.00145	CcSEcCtD
Tamoxifen—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.000224	0.00145	CcSEcCtD
Tamoxifen—Anxiety—Methylprednisolone—ankylosing spondylitis	0.000223	0.00145	CcSEcCtD
Tamoxifen—Depression—Methotrexate—ankylosing spondylitis	0.000222	0.00144	CcSEcCtD
Tamoxifen—Flushing—Prednisone—ankylosing spondylitis	0.000222	0.00144	CcSEcCtD
Tamoxifen—Discomfort—Triamcinolone—ankylosing spondylitis	0.000222	0.00144	CcSEcCtD
Tamoxifen—Discomfort—Methylprednisolone—ankylosing spondylitis	0.000221	0.00144	CcSEcCtD
Tamoxifen—Stevens-Johnson syndrome—Methotrexate—ankylosing spondylitis	0.000221	0.00143	CcSEcCtD
Tamoxifen—Dry mouth—Triamcinolone—ankylosing spondylitis	0.00022	0.00142	CcSEcCtD
Tamoxifen—Angioedema—Dexamethasone—ankylosing spondylitis	0.000219	0.00142	CcSEcCtD
Tamoxifen—Angioedema—Betamethasone—ankylosing spondylitis	0.000219	0.00142	CcSEcCtD
Tamoxifen—Oedema—Triamcinolone—ankylosing spondylitis	0.000215	0.0014	CcSEcCtD
Tamoxifen—Arrhythmia—Prednisone—ankylosing spondylitis	0.000214	0.00139	CcSEcCtD
Tamoxifen—Infection—Triamcinolone—ankylosing spondylitis	0.000214	0.00139	CcSEcCtD
Tamoxifen—Sweating—Methotrexate—ankylosing spondylitis	0.000214	0.00139	CcSEcCtD
Tamoxifen—Infection—Methylprednisolone—ankylosing spondylitis	0.000213	0.00138	CcSEcCtD
Tamoxifen—Insomnia—Prednisolone—ankylosing spondylitis	0.000212	0.00137	CcSEcCtD
Tamoxifen—Alopecia—Prednisone—ankylosing spondylitis	0.000212	0.00137	CcSEcCtD
Tamoxifen—Paraesthesia—Prednisolone—ankylosing spondylitis	0.00021	0.00136	CcSEcCtD
Tamoxifen—Erythema—Prednisone—ankylosing spondylitis	0.000208	0.00135	CcSEcCtD
Tamoxifen—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.000208	0.00135	CcSEcCtD
Tamoxifen—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.000208	0.00135	CcSEcCtD
Tamoxifen—Hypertension—Dexamethasone—ankylosing spondylitis	0.000207	0.00134	CcSEcCtD
Tamoxifen—Hypertension—Betamethasone—ankylosing spondylitis	0.000207	0.00134	CcSEcCtD
Tamoxifen—Myalgia—Betamethasone—ankylosing spondylitis	0.000204	0.00132	CcSEcCtD
Tamoxifen—Myalgia—Dexamethasone—ankylosing spondylitis	0.000204	0.00132	CcSEcCtD
Tamoxifen—Anxiety—Dexamethasone—ankylosing spondylitis	0.000203	0.00132	CcSEcCtD
Tamoxifen—Anxiety—Betamethasone—ankylosing spondylitis	0.000203	0.00132	CcSEcCtD
Tamoxifen—Discomfort—Dexamethasone—ankylosing spondylitis	0.000201	0.00131	CcSEcCtD
Tamoxifen—Discomfort—Betamethasone—ankylosing spondylitis	0.000201	0.00131	CcSEcCtD
Tamoxifen—Haemoglobin—Methotrexate—ankylosing spondylitis	0.000201	0.0013	CcSEcCtD
Tamoxifen—Pain—Prednisolone—ankylosing spondylitis	0.0002	0.0013	CcSEcCtD
Tamoxifen—Hepatitis—Methotrexate—ankylosing spondylitis	0.0002	0.0013	CcSEcCtD
Tamoxifen—Haemorrhage—Methotrexate—ankylosing spondylitis	0.0002	0.0013	CcSEcCtD
Tamoxifen—Pharyngitis—Methotrexate—ankylosing spondylitis	0.000199	0.00129	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000196	0.00127	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000196	0.00127	CcSEcCtD
Tamoxifen—Oedema—Dexamethasone—ankylosing spondylitis	0.000195	0.00127	CcSEcCtD
Tamoxifen—Oedema—Betamethasone—ankylosing spondylitis	0.000195	0.00127	CcSEcCtD
Tamoxifen—Insomnia—Triamcinolone—ankylosing spondylitis	0.000195	0.00126	CcSEcCtD
Tamoxifen—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000194	0.00126	CcSEcCtD
Tamoxifen—Infection—Betamethasone—ankylosing spondylitis	0.000194	0.00126	CcSEcCtD
Tamoxifen—Infection—Dexamethasone—ankylosing spondylitis	0.000194	0.00126	CcSEcCtD
Tamoxifen—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000193	0.00125	CcSEcCtD
Tamoxifen—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000193	0.00125	CcSEcCtD
Tamoxifen—Visual impairment—Methotrexate—ankylosing spondylitis	0.000193	0.00125	CcSEcCtD
Tamoxifen—Anaemia—Prednisone—ankylosing spondylitis	0.000193	0.00125	CcSEcCtD
Tamoxifen—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000192	0.00125	CcSEcCtD
Tamoxifen—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000191	0.00124	CcSEcCtD
Tamoxifen—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000191	0.00124	CcSEcCtD
Tamoxifen—Angioedema—Prednisone—ankylosing spondylitis	0.00019	0.00124	CcSEcCtD
Tamoxifen—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.00019	0.00123	CcSEcCtD
Tamoxifen—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.000189	0.00123	CcSEcCtD
Tamoxifen—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000189	0.00123	CcSEcCtD
Tamoxifen—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.000189	0.00123	CcSEcCtD
Tamoxifen—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.000189	0.00123	CcSEcCtD
Tamoxifen—Anorexia—Dexamethasone—ankylosing spondylitis	0.000186	0.00121	CcSEcCtD
Tamoxifen—Anorexia—Betamethasone—ankylosing spondylitis	0.000186	0.00121	CcSEcCtD
Tamoxifen—Urticaria—Prednisolone—ankylosing spondylitis	0.000186	0.00121	CcSEcCtD
Tamoxifen—Fatigue—Triamcinolone—ankylosing spondylitis	0.000186	0.0012	CcSEcCtD
Tamoxifen—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000185	0.0012	CcSEcCtD
Tamoxifen—Pain—Triamcinolone—ankylosing spondylitis	0.000184	0.00119	CcSEcCtD
Tamoxifen—Hypertension—Prednisone—ankylosing spondylitis	0.00018	0.00117	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000178	0.00115	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000178	0.00115	CcSEcCtD
Tamoxifen—Myalgia—Prednisone—ankylosing spondylitis	0.000177	0.00115	CcSEcCtD
Tamoxifen—Arthralgia—Prednisone—ankylosing spondylitis	0.000177	0.00115	CcSEcCtD
Tamoxifen—Anxiety—Prednisone—ankylosing spondylitis	0.000177	0.00115	CcSEcCtD
Tamoxifen—Alopecia—Methotrexate—ankylosing spondylitis	0.000177	0.00115	CcSEcCtD
Tamoxifen—Insomnia—Betamethasone—ankylosing spondylitis	0.000177	0.00115	CcSEcCtD
Tamoxifen—Insomnia—Dexamethasone—ankylosing spondylitis	0.000177	0.00115	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000176	0.00114	CcSEcCtD
Tamoxifen—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000175	0.00114	CcSEcCtD
Tamoxifen—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000175	0.00114	CcSEcCtD
Tamoxifen—Discomfort—Prednisone—ankylosing spondylitis	0.000175	0.00114	CcSEcCtD
Tamoxifen—Erythema—Methotrexate—ankylosing spondylitis	0.000174	0.00113	CcSEcCtD
Tamoxifen—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000173	0.00112	CcSEcCtD
Tamoxifen—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000172	0.00112	CcSEcCtD
Tamoxifen—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000172	0.00112	CcSEcCtD
Tamoxifen—Urticaria—Triamcinolone—ankylosing spondylitis	0.000171	0.00111	CcSEcCtD
Tamoxifen—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000171	0.00111	CcSEcCtD
Tamoxifen—Dysgeusia—Methotrexate—ankylosing spondylitis	0.000171	0.00111	CcSEcCtD
Tamoxifen—Oedema—Prednisone—ankylosing spondylitis	0.00017	0.0011	CcSEcCtD
Tamoxifen—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.00017	0.0011	CcSEcCtD
Tamoxifen—Decreased appetite—Betamethasone—ankylosing spondylitis	0.00017	0.0011	CcSEcCtD
Tamoxifen—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.00017	0.0011	CcSEcCtD
Tamoxifen—Infection—Prednisone—ankylosing spondylitis	0.000169	0.0011	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000169	0.00109	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000169	0.00109	CcSEcCtD
Tamoxifen—Back pain—Methotrexate—ankylosing spondylitis	0.000169	0.00109	CcSEcCtD
Tamoxifen—Fatigue—Betamethasone—ankylosing spondylitis	0.000168	0.00109	CcSEcCtD
Tamoxifen—Fatigue—Dexamethasone—ankylosing spondylitis	0.000168	0.00109	CcSEcCtD
Tamoxifen—Pain—Betamethasone—ankylosing spondylitis	0.000167	0.00108	CcSEcCtD
Tamoxifen—Pain—Dexamethasone—ankylosing spondylitis	0.000167	0.00108	CcSEcCtD
Tamoxifen—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.000164	0.00107	CcSEcCtD
Tamoxifen—Anorexia—Prednisone—ankylosing spondylitis	0.000162	0.00105	CcSEcCtD
Tamoxifen—Anaemia—Methotrexate—ankylosing spondylitis	0.000161	0.00104	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.00016	0.00104	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.00016	0.00104	CcSEcCtD
Tamoxifen—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000159	0.00103	CcSEcCtD
Tamoxifen—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000158	0.00103	CcSEcCtD
Tamoxifen—Leukopenia—Methotrexate—ankylosing spondylitis	0.000156	0.00101	CcSEcCtD
Tamoxifen—Urticaria—Dexamethasone—ankylosing spondylitis	0.000155	0.00101	CcSEcCtD
Tamoxifen—Urticaria—Betamethasone—ankylosing spondylitis	0.000155	0.00101	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000155	0.00101	CcSEcCtD
Tamoxifen—Dizziness—Prednisolone—ankylosing spondylitis	0.000155	0.001	CcSEcCtD
Tamoxifen—Asthenia—Triamcinolone—ankylosing spondylitis	0.000154	0.001	CcSEcCtD
Tamoxifen—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000154	0.001	CcSEcCtD
Tamoxifen—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000154	0.001	CcSEcCtD
Tamoxifen—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000154	0.001	CcSEcCtD
Tamoxifen—Insomnia—Prednisone—ankylosing spondylitis	0.000154	0.000998	CcSEcCtD
Tamoxifen—Paraesthesia—Prednisone—ankylosing spondylitis	0.000153	0.000991	CcSEcCtD
Tamoxifen—Pruritus—Triamcinolone—ankylosing spondylitis	0.000152	0.000988	CcSEcCtD
Tamoxifen—Cough—Methotrexate—ankylosing spondylitis	0.000152	0.000986	CcSEcCtD
Tamoxifen—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000152	0.000986	CcSEcCtD
Tamoxifen—Dyspepsia—Prednisone—ankylosing spondylitis	0.00015	0.000972	CcSEcCtD
Tamoxifen—Myalgia—Methotrexate—ankylosing spondylitis	0.000148	0.000962	CcSEcCtD
Tamoxifen—Chest pain—Methotrexate—ankylosing spondylitis	0.000148	0.000962	CcSEcCtD
Tamoxifen—Arthralgia—Methotrexate—ankylosing spondylitis	0.000148	0.000962	CcSEcCtD
Tamoxifen—Decreased appetite—Prednisone—ankylosing spondylitis	0.000148	0.000959	CcSEcCtD
Tamoxifen—Rash—Prednisolone—ankylosing spondylitis	0.000148	0.000958	CcSEcCtD
Tamoxifen—Dermatitis—Prednisolone—ankylosing spondylitis	0.000148	0.000957	CcSEcCtD
Tamoxifen—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000147	0.000954	CcSEcCtD
Tamoxifen—Fatigue—Prednisone—ankylosing spondylitis	0.000147	0.000952	CcSEcCtD
Tamoxifen—Headache—Prednisolone—ankylosing spondylitis	0.000147	0.000951	CcSEcCtD
Tamoxifen—Discomfort—Methotrexate—ankylosing spondylitis	0.000147	0.000951	CcSEcCtD
Tamoxifen—Constipation—Prednisone—ankylosing spondylitis	0.000146	0.000944	CcSEcCtD
Tamoxifen—Dizziness—Triamcinolone—ankylosing spondylitis	0.000142	0.000924	CcSEcCtD
Tamoxifen—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000142	0.000922	CcSEcCtD
Tamoxifen—Infection—Methotrexate—ankylosing spondylitis	0.000141	0.000916	CcSEcCtD
Tamoxifen—Asthenia—Betamethasone—ankylosing spondylitis	0.00014	0.000909	CcSEcCtD
Tamoxifen—Asthenia—Dexamethasone—ankylosing spondylitis	0.00014	0.000909	CcSEcCtD
Tamoxifen—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000139	0.000903	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000139	0.000903	CcSEcCtD
Tamoxifen—Nausea—Prednisolone—ankylosing spondylitis	0.000139	0.000902	CcSEcCtD
Tamoxifen—Pruritus—Dexamethasone—ankylosing spondylitis	0.000138	0.000897	CcSEcCtD
Tamoxifen—Pruritus—Betamethasone—ankylosing spondylitis	0.000138	0.000897	CcSEcCtD
Tamoxifen—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.000137	0.000892	CcSEcCtD
Tamoxifen—Vomiting—Triamcinolone—ankylosing spondylitis	0.000137	0.000888	CcSEcCtD
Tamoxifen—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000137	0.000886	CcSEcCtD
Tamoxifen—Rash—Triamcinolone—ankylosing spondylitis	0.000136	0.000881	CcSEcCtD
Tamoxifen—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000136	0.00088	CcSEcCtD
Tamoxifen—Anorexia—Methotrexate—ankylosing spondylitis	0.000136	0.000879	CcSEcCtD
Tamoxifen—Rash—Methylprednisolone—ankylosing spondylitis	0.000135	0.000879	CcSEcCtD
Tamoxifen—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000135	0.000878	CcSEcCtD
Tamoxifen—Urticaria—Prednisone—ankylosing spondylitis	0.000135	0.000877	CcSEcCtD
Tamoxifen—Headache—Triamcinolone—ankylosing spondylitis	0.000135	0.000875	CcSEcCtD
Tamoxifen—Headache—Methylprednisolone—ankylosing spondylitis	0.000135	0.000873	CcSEcCtD
Tamoxifen—Abdominal pain—Prednisone—ankylosing spondylitis	0.000135	0.000872	CcSEcCtD
Tamoxifen—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000134	0.000867	CcSEcCtD
Tamoxifen—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000134	0.000867	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.00013	0.00084	CcSEcCtD
Tamoxifen—Dizziness—Dexamethasone—ankylosing spondylitis	0.000129	0.000838	CcSEcCtD
Tamoxifen—Dizziness—Betamethasone—ankylosing spondylitis	0.000129	0.000838	CcSEcCtD
Tamoxifen—Insomnia—Methotrexate—ankylosing spondylitis	0.000129	0.000834	CcSEcCtD
Tamoxifen—Nausea—Triamcinolone—ankylosing spondylitis	0.000128	0.00083	CcSEcCtD
Tamoxifen—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000128	0.000828	CcSEcCtD
Tamoxifen—Nausea—Methylprednisolone—ankylosing spondylitis	0.000128	0.000828	CcSEcCtD
Tamoxifen—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000127	0.000822	CcSEcCtD
Tamoxifen—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000125	0.000813	CcSEcCtD
Tamoxifen—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000125	0.000812	CcSEcCtD
Tamoxifen—Vomiting—Dexamethasone—ankylosing spondylitis	0.000124	0.000806	CcSEcCtD
Tamoxifen—Vomiting—Betamethasone—ankylosing spondylitis	0.000124	0.000806	CcSEcCtD
Tamoxifen—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000124	0.000802	CcSEcCtD
Tamoxifen—Rash—Dexamethasone—ankylosing spondylitis	0.000123	0.000799	CcSEcCtD
Tamoxifen—Rash—Betamethasone—ankylosing spondylitis	0.000123	0.000799	CcSEcCtD
Tamoxifen—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000123	0.000798	CcSEcCtD
Tamoxifen—Dermatitis—Betamethasone—ankylosing spondylitis	0.000123	0.000798	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000123	0.000796	CcSEcCtD
Tamoxifen—Fatigue—Methotrexate—ankylosing spondylitis	0.000123	0.000795	CcSEcCtD
Tamoxifen—Headache—Dexamethasone—ankylosing spondylitis	0.000122	0.000794	CcSEcCtD
Tamoxifen—Headache—Betamethasone—ankylosing spondylitis	0.000122	0.000794	CcSEcCtD
Tamoxifen—Asthenia—Prednisone—ankylosing spondylitis	0.000122	0.000792	CcSEcCtD
Tamoxifen—Pain—Methotrexate—ankylosing spondylitis	0.000122	0.000789	CcSEcCtD
Tamoxifen—Pruritus—Prednisone—ankylosing spondylitis	0.00012	0.000781	CcSEcCtD
Tamoxifen—Diarrhoea—Prednisone—ankylosing spondylitis	0.000116	0.000755	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000116	0.000754	CcSEcCtD
Tamoxifen—Nausea—Betamethasone—ankylosing spondylitis	0.000116	0.000753	CcSEcCtD
Tamoxifen—Nausea—Dexamethasone—ankylosing spondylitis	0.000116	0.000753	CcSEcCtD
Tamoxifen—Urticaria—Methotrexate—ankylosing spondylitis	0.000113	0.000733	CcSEcCtD
Tamoxifen—Dizziness—Prednisone—ankylosing spondylitis	0.000113	0.00073	CcSEcCtD
Tamoxifen—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000112	0.000729	CcSEcCtD
Tamoxifen—Vomiting—Prednisone—ankylosing spondylitis	0.000108	0.000702	CcSEcCtD
Tamoxifen—Rash—Prednisone—ankylosing spondylitis	0.000107	0.000696	CcSEcCtD
Tamoxifen—Dermatitis—Prednisone—ankylosing spondylitis	0.000107	0.000695	CcSEcCtD
Tamoxifen—Headache—Prednisone—ankylosing spondylitis	0.000107	0.000691	CcSEcCtD
Tamoxifen—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000105	0.00068	CcSEcCtD
Tamoxifen—Asthenia—Methotrexate—ankylosing spondylitis	0.000102	0.000662	CcSEcCtD
Tamoxifen—Nausea—Prednisone—ankylosing spondylitis	0.000101	0.000656	CcSEcCtD
Tamoxifen—Pruritus—Methotrexate—ankylosing spondylitis	0.000101	0.000653	CcSEcCtD
Tamoxifen—Diarrhoea—Methotrexate—ankylosing spondylitis	9.73e-05	0.000631	CcSEcCtD
Tamoxifen—Dizziness—Methotrexate—ankylosing spondylitis	9.4e-05	0.00061	CcSEcCtD
Tamoxifen—Vomiting—Methotrexate—ankylosing spondylitis	9.04e-05	0.000586	CcSEcCtD
Tamoxifen—Rash—Methotrexate—ankylosing spondylitis	8.97e-05	0.000582	CcSEcCtD
Tamoxifen—Dermatitis—Methotrexate—ankylosing spondylitis	8.96e-05	0.000581	CcSEcCtD
Tamoxifen—Headache—Methotrexate—ankylosing spondylitis	8.91e-05	0.000578	CcSEcCtD
Tamoxifen—Nausea—Methotrexate—ankylosing spondylitis	8.45e-05	0.000548	CcSEcCtD
